Effects of calcium dobesilate upon thurfyl nicotinate erythema in man.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002118:Calcium; D002199:Capillary Permeability / Q000187:drug effects; D004890:Erythema / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D012737:Sex Factors; D013451:Sulfonic Acids / Q000008:administration & dosage / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D000644:Quaternary Ammonium Compounds; D013451:Sulfonic Acids; D002118:Calcium